Results 11 to 20 of about 1,379 (132)
Indian Journal of Critical Care Medicine, 2022 How to cite this article: Hegde A. Candida auris is Coming. Indian J Crit Care Med 2022;26(5):543-544.
openaire +2 more sources
, 2023 Candida türlerinin neden olduğu enfeksiyonlar günümüzde yoğun bakım hastaları, immun sistemi baskılanmış hastalar gibi özellikli hastalarda ciddi morbidite ve mortalite kaynağı olarak giderek artan oranda karşımıza çıkmaktadır.
AKKAYA, Yüksel, ERDIN, Begüm Nalça
openaire +2 more sources
PLoS ONE, 2023 Candida auris is a multidrug-resistant pathogen, that is a well-known cause of nosocomial infections. This pathogen is being identified using advanced diagnostic approaches and epidemiological typing procedures.
Zill-E- Huma +5 more
doaj +1 more source
Frontiers in Cellular and Infection Microbiology, 2023 The surge of multidrug-resistant fungal pathogens, especially Candida auris, poses significant threats to global public health. Candida auris exhibits resistance to multiple antifungal drugs, leading to major outbreaks and a high mortality rate.
Ji-Seok Kim +2 more
doaj +1 more source
Cell Viability Assays for Candida auris [PDF]
, 2022 Cell viability assays are useful for assessing the efficacy of antifungal therapeutics and disinfection strategies in vitro. In recent years these assays have been fundamental for the testing of conventional and novel therapies against the nosocomial fungal pathogen Candida auris.
Brown, Jason L. +5 more
openaire +2 more sources
Candida auris Genetics and Emergence
Annual Review of Microbiology, 2023 Candida auris is a multidrug-resistant fungal pathogen that presents a serious threat to global human health. Since the first reported case in 2009 in Japan, C. auris infections have been reported in more than 40 countries, with mortality rates between 30% and 60%. In addition, C.
Anuradha Chowdhary +2 more
openaire +2 more sources
Comparative evaluation of enzyme and biocidal activity of Candida auris and Candida albicans
Журнал микробиологии, эпидемиологии и иммунобиологии, 2023 Introduction. Secreted metabolites with enzymatic or toxic properties are important for effecting of Candida spp pathogenicity. The most clinically significant species is C. albicans. However, invasive infections associated with C.
Nadezhda I. Ignatova +5 more
doaj +1 more source
Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait. [PDF]
PLoS ONE, 2018 Candida auris is an emerging yeast pathogen of global significance. Its multidrug-resistant nature and inadequacies of conventional identification systems pose diagnostic and therapeutic challenges. This study investigated occurrence of C.
Ziauddin Khan +5 more
doaj +1 more source
Journal of Fungi, 2023 Candida auris is an emerging global public health threat and is resistant to most antifungal agents. Though fungi are significant pathogens for animals, the role of C. auris in animal health remains unexplored. Here, we analysed the microbial cultures of skin and ear swabs of 87 dogs in Delhi and performed fungal meta-barcode sequencing of ear and skin
Anamika Yadav +7 more
openaire +3 more sources
Comparison of Two Commercially Available qPCR Kits for the Detection of Candida auris
Journal of Fungi, 2021 Candida auris is an emerging pathogen with resistance to many commonly used antifungal agents. Infections with C. auris require rapid and reliable detection methods to initiate successful medical treatment and contain hospital outbreaks.
Janko Sattler +7 more
doaj +1 more source